Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B.

[1]  D. Galton.  The myelodysplastic syndromes. Part I. What are they? Part II. Classification. , 2009, Scandinavian journal of haematology. Supplementum.

[2]  P. Ruutu.  Granulocyte function in myelodysplastic syndromes. , 2009, Scandinavian journal of haematology. Supplementum.

[3]  K. Byth,et al.  The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution , 1995, British journal of haematology.

[4]  L. Kjeldsen,et al.  Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. , 1995, Journal of immunology.

[5]  H. Mizoguchi,et al.  Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. , 1995, Leukemia research.

[6]  U. Germing,et al.  Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score. , 1994, Leukemia.

[7]  F. Lanza,et al.  Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status. , 1994, Leukemia & lymphoma.

[8]  H. Sengeløv,et al.  Human neutrophil granules and secretory vesicles , 1993, European journal of haematology.

[9]  T. Felzmann,et al.  Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndrome , 1993, British journal of haematology.

[10]  G. Ricevuti,et al.  The CD11/CD18 granulocyte adhesion molecules in myelodysplastic syndromes , 1993, British journal of haematology.

[11]  C. Bloomfield,et al.  The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells. , 1992, American journal of clinical pathology.

[12]  T. Hamblin.  Immunologic abnormalities in myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.

[13]  E. Buescher,et al.  Functional, physical, and ultrastructural localization of CD15 antigens to the human polymorphonuclear leukocyte secondary granule , 1990, The Anatomical record.

[14]  G. Zei,et al.  Risk assessment in myelodysplastic syndromes: Value of clinical, hematologic and bone marrow histologic findings at presentation , 1990, European journal of haematology.

[15]  M. Cazzola,et al.  Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system. , 1990, Haematologica.

[16]  M. Kerr,et al.  Characterization of human neutrophil glycoproteins expressing the CD15 differentiation antigen (3‐fucosyl‐N‐acetyllactosamine) , 1989, British journal of haematology.

[17]  P. Beris.  Primary clonal myelodysplastic syndromes. , 1989, Seminars in hematology.

[18]  D. Mason,et al.  Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. , 1988, Human pathology.

[19]  P. Colombat,et al.  Immunologic indices in myelodysplastic syndromes , 1988, Cancer.

[20]  L. Boxer,et al.  Neutrophil granule constituents and their release in health and disease. , 1988, Hematology/oncology clinics of North America.

[21]  D. Galton.  The myelodysplastic syndromes. , 1987, Clinical and laboratory haematology.

[22]  T. Economopoulos,et al.  Myelodysplastic syndromes: Analysis of 131 cases according to the FAB classification , 1987, European journal of haematology.

[23]  J. Armitage,et al.  Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases , 1985, Cancer.

[24]  D. Weisdorf,et al.  Monoclonal antibody AHN-1 inhibits phagocytosis by human neutrophils. , 1985, Blood.

[25]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  M. Boogaerts,et al.  Blood neutrophil function in primary myelodysplastic syndromes , 1983, British journal of haematology.

[27]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[28]  J. Goasguen,et al.  Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system. , 1990, Leukemia research.

[29]  J. Lister,et al.  Deficiency of a major myeloid antigen in neutrophils of patients with refractory anemia and excess myeloblasts. , 1985, Leukemia research.

[30]  A. Sullivan,et al.  Antigens differentially expressed on surface and cytoplasmic structures of human myeloid cells. , 1985, Leukemia research.